Toggle navigation
Home
Search
Services
Blog
Contact
About
Production of A Recombinant H5 N1 Vaccine for Phase 1
Smith, Gail
Protein Sciences Corporation, Meriden, CT, United States
Search 21 grants from Gail Smith
Search grants from Protein Sciences Corporation
Share this grant:
:
:
Abstract
Funding
Institution
Related projects
Comments
Recent in Grantomics:
Your institution
vs. funders. Who wins?
Read more...
How should you pick the next fundable research topic?
Read more...
Recently viewed grants:
Treatment of Obstructive Sleep Apnea After Stroke
KLF4 monocyte biology and vascular injury
Deleterious Products of Plasma Cell Dyscrasias
Characterization of the Pertussis Toxin Secretion Operon
SEES Fellows: A bio-economic study of an introduced biological control agent: ecological, evolutionary, and economic factors in sustainable agricultural systems
Recently added grants:
A Novel Probiotic-Based Nanobody Delivery Platform
Mechanisms of Dopamine Action in Learning: Implications for Addiction
Individual genomic analyses to discover the molecular basis and mechanisms contributing to adult-onset disease
Selective Glucocorticoid Action in the Developing Brain
Longitudinal Cognitive and Emotional Development in Working Dogs
Abstract
Funding Agency
Agency
National Institute of Health (NIH)
Institute
National Institute of Allergy and Infectious Diseases (NIAID)
Type
Research and Development Contracts (N01)
Project #
N01AI085333-000
Application #
2711335
Study Section
Project Start
1997-12-19
Project End
Budget Start
1997-12-19
Budget End
1998-04-18
Support Year
Fiscal Year
1998
Total Cost
Indirect Cost
Institution
Name
Protein Sciences Corporation
Department
Type
DUNS #
City
Meriden
State
CT
Country
United States
Zip Code
06450
Related projects
NIH 1998
N01 AI
Production of A Recombinant H5 N1 Vaccine for Phase 1
Smith, Gail / Protein Sciences Corporation
NIH 1998
N01 AI
Production of A Recombinant H5 N1 Vaccine for Phase 1
Smith, Gail / Protein Sciences Corporation
Comments
Be the first to comment on this grant